Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
109 participants
OBSERVATIONAL
2014-07-31
2019-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- Computed tomography (CT) scanning is a procedure that helps doctors with diagnoses. It uses X-ray radiation to produce an image in three dimensions. Researchers want to study how to get the best quality CT scans using the lowest possible radiation dose.
Objective:
\- To determine how to improve CT scanning.
Eligibility:
\- Adults 45 years of age and older who have not had a CT scan in the past year and do not have kidney disease.
Design:
* Participants will be screened with a medical history and blood and urine tests.
* Nurses will put an intravenous (IV) line into an arm or hand vein. It will stay in for several hours during the magnetic resonance imaging (MRI) and CT scans. Through this IV, blood will be taken, dye will be injected, and medicine will be given.
* Participants may have a CT scan of the heart, head, chest, abdomen, and/or pelvis. Participants will lie on their back on a table. The table will slide into a donut-shaped machine. An X-ray tube will move around the body, taking pictures.
* Participants may be given a drug called a beta blocker by mouth or through the IV tube.
* Participants heart rate and blood pressure will be monitored.
* Participants may have an MRI scan. The MRI is a large hollow tube. The participant will lie on a table that will be moved into the tube, which contains a magnetic field. When the imaging starts, a thumping sound will be heard. Headphones or earplugs will be provided to muffle the sound.
* Participants will give blood samples.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of CARESTREAM Cone Beam Computed Tomography (CBCT)
NCT02445287
Decision Making in Degenerative Lumbar Spine : CT vs. MRI
NCT04130035
Interest of the Cone-beam Computed Tomography in the Imagery of the Middle Ear
NCT02896764
320-slice Coronary Computed Tomography (CT) Angiography
NCT00721851
Effect of Three Side Hole Infusion Catheter on CT Image Quality Compared to a Standard Infusion Catheter
NCT02943226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lab Eligibility parameters:
* For CT and MRI contrast enhanced scans:
---eGFR greater than or equal to 60 mL/min/1.73m(2) within 7 days prior to scanning
* For female participants ages 45-60 within 3 days prior to scan (unless post-menopausal or no longer able to bear children, note exemption on initial visit):
* Pregnancy test result(blood or urine): Negative
* Willing to travel to the NIH for follow-up visits.
* Greater than or equal to 45 years old
* Able to understand and sign informed consent
* Stable clinical status
* Volunteer indicates no history of participation in NIH protocols using research radiation in the last 12 months (e.g. PET research scans, NCI Molecular Imaging Center PET scans, etc)
Exclusion Criteria
* Pregnant women
* Over 500 lbs and/or a body circumference that prevents the study subject from lying flat in the scanner
* Claustrophobia requiring sedation or anesthesia.
* Known or suspected genetic predisposition to cancer
* Any contraindications that the research team identifies from the subject, radiology department CT and/or MRI questionnaires, and/or History and Assessment.
Exclusion for participation for iodinated contrast for CT
* Allergy to iodinated contrast for scans (study subject will be eligible for non-contrast scans)
* Acute renal failure, renal transplant, dialysis and renal failure (clinically diagnosed).\<TAB\>
* Lactating women
* Patient preference to not undergo intravenous line placement and/or receive iodinated contrast. Contrast administration is optional and participants may still undergo a non-contrast study.
* Use of metformin-containing products less than 24 hours prior To CT contrast administration
* Other contraindications to iodinated contrast media as determined by the research team.
Exclusion for participation for Gadolinium contrast for MRI
* Allergy to gadolinium for scans using contrast; will be eligible for non-contrast scans.
* Acute renal failure, renal transplant, dialysis and renal failure individuals ( Lab Eligibility parameters and/or clinically diagnosed).\<TAB\>
* Lactating women
* Patient preference to not undergo intravenous line placement and/or receive gadolinium contrast. Contrast administration is optional and participants may still undergo a non-contrast study.
* Other contraindications to gadolinium contrast media as determined by the research team.
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health Clinical Center (CC)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David A Bluemke, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institutes of Health Clinical Center (CC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Halliburton S, Arbab-Zadeh A, Dey D, Einstein AJ, Gentry R, George RT, Gerber T, Mahesh M, Weigold WG. State-of-the-art in CT hardware and scan modes for cardiovascular CT. J Cardiovasc Comput Tomogr. 2012 May-Jun;6(3):154-63. doi: 10.1016/j.jcct.2012.04.005. Epub 2012 Apr 7.
Trattner S, Pearson GDN, Chin C, Cody DD, Gupta R, Hess CP, Kalra MK, Kofler JM Jr, Krishnam MS, Einstein AJ. Standardization and optimization of CT protocols to achieve low dose. J Am Coll Radiol. 2014 Mar;11(3):271-278. doi: 10.1016/j.jacr.2013.10.016.
Mahesh M. Variability in CT protocols. J Am Coll Radiol. 2013 Oct;10(10):805-6. doi: 10.1016/j.jacr.2013.07.005. Epub 2013 Aug 26. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-CC-0158
Identifier Type: -
Identifier Source: secondary_id
140158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.